also generates real-world evidence that helps demonstrate the value of treatments and improve future care. For more information please visit, www.sciensus.com
next step in Kodak’s phased expansion of its pharmaceutical portfolio, which includes Water for Injection and multiple PBS formulations, with additional products planned. Kodak is also progressing toward the introduction of Class II products as...
Alchemy 21/12 introduced Oleotide™ — a modular biotechnology platform built around the coordination of biological signals and the conditions that support skin renewal. The company describes its first-of-its-kind architecture through five...
botulinum toxin brand to the international medical aesthetics industry. SOLTOX is presented in 100 Unit and 200 Unit formulations with three defining technical characteristics: a 900 kDa toxin complex, a freeze dried dosage form, and an advanced...
July 2026, and brings complementary expertise together across the injectable value chain. As biologics, high-concentration formulations, and combination products continue to increase in complexity, pharma companies face growing challenges in...
alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery,...
alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery,...
MEPSGEN US, Inc., a global innovator in drug delivery system platforms, announced the launch of NanoCalibur® Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug discovery and development. Nanoparticles...
the development, industrialization and commercialization of PULMOTREE’s Kolibri™ Non-Propellant Liquid Inhaler (NPLI) platform. The acquisition is intended to expand Aptar Pharma’s opportunities for growth in respiratory drug delivery by adding a...
prescription-only pharmaceutical-grade Niagen™ At-Home Injection Kit, featuring the Company’s first ready-to-inject liquid formulation with Niagen™ (patented nicotinamide riboside, or NR), the most studied, high-quality NAD+ precursor brand...
strategy and business development. She brings extensive experience in global customer relationships, growth and transformation, operational performance and building highly engaged teams. Earlier in her career, Maes worked at McKinsey & Company,...
biopharma company, shared the first data from a global Phase 1b clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) in combination with atezolizumab with and without carboplatin as first-line treatment for extensive-stage...
Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...
the first dermatologist-tested topical product powered by Niagen® (patented nicotinamide riboside, or NR, a unique form of vitamin B3), the same ingredient in Tru Niagen® supplements, now in topical form. Delivered in a waterless, precision-dosed...
and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...
brings together scientists, researchers, industry leaders, regulators, and healthcare professionals to discuss transformative advancements in drug discovery, development, delivery systems, personalized medicine, and digital health. At NextGen...
AGILITY, the results demonstrated strong safety and effectiveness outcomes in patients with iliac artery disease, a common form of peripheral artery disease (PAD). The findings mark an important milestone in the efforts by BD to expand clinical...
working with SEVER Life Sciences / Nordic Pharma, and other factors that could influence the business and financial performance of SEVER Life Sciences / Nordic Pharma. SEVER Life Sciences / Nordic Pharma assumes no obligation to publicly update any...
thus far" said Thomas Rossi, PhD, Chairman of the Board of Arkayli Biopharma, Inc., "completing the preclinical research, formulation, and manufacturing preparation to support the IND filing. We look forward to entering the clinic with ARK001."...
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing...